Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · Real-Time Price · USD

4.850

-0.030 (-0.61%)

At close: Sep 25, 2026, 4:00 PM EDT

4.860

+0.010 (0.21%)

After-hours: Sep 25, 2026, 7:57 PM EDT

Arbutus Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	960	925	620	419	365	526
Market Cap Growth	12.23%	49.29%	47.80%	15.00%	-30.72%	74.57%
Enterprise Value	871	836	496	285	189	556
Last Close Price	4.85	4.81	3.27	2.50	2.33	3.89

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	236.87	236.87	236.87	236.87	236.87
PS Ratio	5.28	65.69	100.41	23.11	9.34	47.89
PB Ratio	3.70	12.08	6.36	3.95	2.66	3.11
P/TBV Ratio	3.71	12.08	6.36	3.95	2.66	3.11

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.79	59.36	80.32	15.69	4.85	50.59

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.06	0.06	0.08	0.09	0.11
Net Debt / Equity Ratio	-0.34	-1.14	-1.20	-1.17	-1.25	-1.02
Net Debt / EBITDA Ratio	-0.60	3.27	1.70	1.61	2.78	2.46
Net Debt / FCF Ratio	3.61	2.20	1.79	1.42	4.79	2.52
Asset Turnover	0.96	0.12	0.05	0.11	0.20	0.06
Quick Ratio	81.08	15.52	8.03	5.71	4.51	13.92
Current Ratio	81.42	15.73	8.15	5.87	4.60	14.32
Return on Equity (ROE)	89.58%	-38.52%	-68.76%	-59.99%	-45.35%	-56.19%
Return on Assets (ROA)	48.84%	-14.94%	-31.68%	-28.70%	-19.76%	-26.22%
Return on Capital Employed (ROCE)	54.50%	-30.50%	-60.30%	-64.00%	-38.90%	-37.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	15.95%	-3.62%	-11.28%	-17.38%	-19.05%	-14.49%
FCF Yield	-2.57%	-4.29%	-10.50%	-20.74%	-9.84%	-12.99%
Buyback Yield / Dilution	-2.21%	-3.23%	-11.84%	-9.95%	-42.07%	-40.10%

SEC Filings: 10-K · 10-Q